Tag:
Bayer
Latest Headlines
Latest Headlines
Italians arrested in pay-for-approval scandal
A corruption scandal in Italy -- this time involving a pay-to-play scheme at AIFA, the pharma regulatory agency. Authorities arrested Pasqualino Rossi, Aifa's vice president and a senior rep at the
Is this the end of the Trasylol story?
A new study could be the last nail in Trasylol's coffin. In a head-to-head comparison of Trasylol (aprotinin) and two other anti-bleeding meds, patients getting Trasylol during heart surgery were
Painkillers little help against dementia
Hopes that painkillers might help stave off Alzheimer's disease were dampened by a large new study. Pfizer's Celebrex and the over-the-counter Aleve didn't benefit thinking skills as researchers had
To DTC or not to DTC?
Europe is debating drug marketing--and the pharma industry is loudly protesting that it is not asking for the right to pursue DTC advertising. "[S]uch mass media would not be appropriate means for
SPOTLIGHT: Boehringer beats Bayer drug to market
Boehringer Ingelheim won European approval for its new blood thinner Pradaxa to prevent clotting in patients after orthopedic surgery. The OK lets Pradaxa beat to market its supposed future rival,
Courts more open to patent-busting
Patents aren't just an issue in Thailand, either. These days, drugmakers are having a more difficult time keeping patent protection on their products, the Financial Times notes. Ever since top U.S.
Bayer loses Yasmin patent fight
Bayer had the Yasmin rug pulled out from under it yesterday. A U.S. court voided the contraceptive's key patent, leading the German conglomerate to revise its 2008 profit expectations
Bayer lower 2008 expectations
Call it Bad News Bayer. The German company reported a whopping 78 percent drop in profits for the fourth quarter and forecast 2008 sales growth at its lowest level in years. Though 2007 full-year
Novartis, Novo sue Bayer over patent
Novartis and Novo Nordisk are ganging up on Bayer, alleging that the German company's hemophilia treatment Kogenate infringes on one of their joint patents. In a statement, Bayer said it would
Lawsuit seeks black box on antibiotics
Lobbying didn't work, but maybe a lawsuit will. Public Citizen sued the FDA yesterday, hoping to force the agency to pin stronger warnings on a class of antibiotics known as fluoroquinolones, which
